TriNutra announced that its ThymoQuin ingredient has now been approved as a novel food/dietary supplement by the Thailand Food and Drug Administration.
Black seed oil supplier TriNutra (Harrison, NY) announced that its flagship ThymoQuin ingredient has gained approval for dietary supplements in Thailand. The Thailand Food and Drug Administration approved ThymoQuin as a novel food to be sold in dietary supplements in the region.
“We are incredibly proud to reveal this achievement in Thailand,” said TriNutra’s CEO Morris Zelkha, in a press release. “The sales and awareness of black seed oil continue to grow, and with our exclusive Thailand distribution partner, Aumento Chemical Ltd., we can now offer our clinically studied, high-quality, potent, and bioavailable black seed oil to Thai residents.”
ThymoQuin is standardized to 3% thymoquinone and very low free fatty acid content (below 1.25%), per USP monograph standards. Black seed’s (Nigella sativa) benefits include promoting a balanced inflammatory response; improving mitochondrial activity, including ATP production; and providing good antioxidant and antimicrobial effects. It is currently available for use in regions like North America, Europe, and Asia Pacific.